Cohance ADC Play: Strong Growth Outlook

  Published 9 months ago

Broker cites Cohance’s strong ADC pipeline and growth levers, forecasting robust sales and EBITDA expansion.

  • Integrated ADC services and cross‑selling boost Cohance’s market position amidst easing specialty chemicals destocking pressures
  • Recovery expected by FY26, supporting projected 20% sales CAGR and 26% EBITDA CAGR through FY28
  • Cohance, formed from the Suven merger, offers global CRDMO capabilities targeting innovative pharmaceutical collaborations and growth

You might like these

India to Become 3rd Largest Economy

Ixigo Q1 Profit Jumps 46%

OpenAI Teams Up with Google Cloud for AI Expansion

India Shares Flat Amid Trade Deal Hopes, Jane Street Ban

RBI Intervenes to Stabilize Rupee Amid Oil Price Surge

Reliance Power Reports Mixed Q1

Oil Inventory Surge Signals Price Pressure

News that matters the most ⚡